Table I.
KEGG enrichment analysis results by GSEA.
Pathway name | Gene number of pathway | ES | NES | NOM P-value | FDR q-value |
---|---|---|---|---|---|
Vascular smooth muscle contraction | 110 | −0.608 | −1.726 | 0 | 0.188 |
Vibrio cholerae infection | 50 | 0.566 | 1.879 | 0 | 0.119 |
Toll like receptor signaling | 98 | 0.709 | 1.713 | 0 | 0.147 |
Glycosphingolipid biosynthesis lacto and neolacto series | 26 | 0.603 | 1.712 | 0 | 0.119 |
Cytosolic DNA sensing | 51 | 0.625 | 1.703 | 0 | 0.107 |
N-glycan biosynthesis | 42 | 0.660 | 1.813 | 0.002 | 0.105 |
Amino sugar and nucleotide sugar metabolism | 44 | 0.629 | 1.775 | 0.002 | 0.111 |
Leishmania infection | 62 | 0.779 | 1.554 | 0.004 | 0.127 |
Intestinal immune network for IgA production | 45 | 0.757 | 1.572 | 0.006 | 0.145 |
Colorectal cancer | 61 | 0.438 | 1.486 | 0.006 | 0.151 |
Rig I like receptor signaling | 65 | 0.536 | 1.675 | 0.008 | 0.119 |
P53 signaling | 64 | 0.547 | 1.573 | 0.008 | 0.153 |
Chronic myeloid leukemia | 72 | 0.392 | 1.504 | 0.008 | 0.167 |
Natural killer cell mediated cytotoxicity | 129 | 0.635 | 1.621 | 0.010 | 0.127 |
KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; ES, enrichment score; NES, normalized enrichment score; NOM, nominal; FDR, false discovery rate.